COMMUNIQUÉS West-GlobeNewswire

-
Ardelyx to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024
01/02/2024 -
Immuneering Announces Participation in February Investor Conferences
01/02/2024 -
Acasti Announces Poster Detailing its GTX-104 STRIVE-ON Trial
01/02/2024 -
Windtree Renews Agreement with Chang Gung University for Scientific Collaboration to Further SERCA2a Research
01/02/2024 -
Sensus Healthcare Announces Retirement of Director Samuel O’Rear
01/02/2024 -
Denali Therapeutics Announces Presentations on Its Investigational Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapies at the Upcoming 2024 WORLDSymposium™
01/02/2024 -
BioAdaptives Announces Low-Cost AI FYO Smartphone App Tracking System to Detect Unwanted Muscle Mass Loss Reported With Obesity Management
01/02/2024 -
EDAP Announces Completion of Enrollment in Phase 3 Study Evaluating Focal One HIFU Therapy for the Treatment of Deep Infiltrating Rectal Endometriosis
01/02/2024 -
Tourmaline Bio to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference
01/02/2024 -
NightHawk’s Scorpius BioManufacturing Subsidiary Announces the Promotion of Joe Payne to President and Chief Operating Officer
01/02/2024 -
Prime Medicine to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
01/02/2024 -
Erasca to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
01/02/2024 -
Soleno Therapeutics to Present at Upcoming February Investor Conferences
01/02/2024 -
Ibogaine By David Dardashti Shares Insight On New Study By Stanford University
01/02/2024 -
BioRestorative Therapies to Present Preliminary BRTX-100 Clinical Data at the Orthopaedic Research Society (ORS) 2024 Annual Meeting
01/02/2024 -
Abeona Therapeutics Announces Progress Update on Pz-cel Biologics License Application (BLA)
01/02/2024 -
Anavex Life Sciences to Announce Fiscal 2024 First Quarter Financial Results on Wednesday, February 7th, 2024
01/02/2024 -
Revive Therapeutics Explores the Use of Bucillamine for Long COVID
01/02/2024 -
Quipt Home Medical Corp. to Announce Fiscal First Quarter 2024 Financial Results on February 14, 2024
01/02/2024
Pages